{
    "nct_id": "NCT06400563",
    "official_title": "Evaluation of the Magnetic Resonance-guided (MRg) Near-infrared Spectroscopy (NIRS) Imaging System Platform in Breast Cancer Patients",
    "inclusion_criteria": "1. Females age â‰¥ 18 years old\n2. Participants capable of providing written informed consent\n3. Women with a recent diagnosis of breast cancer.\n4. Women who are in pre-surgical planning must have an estimated tumor size of 2.0 cm or less on available imaging.\n5. Women who are in pre-surgical planning must have had a breast biopsy at least 10 days prior to the MRg-NIRS exam.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 83 Years",
    "exclusion_criteria": "1. Participants with absolute or relative contraindication to MRI:\n\n   1. the presence of an electronic implant, such as a pacemaker\n   2. the presence of a metal implant, such as an aneurysm clip\n   3. claustrophobia\n   4. renal failure (FDA's guidance for gadolinium of a creatinine clearance less than 30 mL/1.73 m2 BSA)\n2. Pregnant women\n3. Breast implants\n4. Prisoners\n5. Participants with visually inadequate healing from breast biopsy.",
    "miscellaneous_criteria": ""
}